title: [Case of Acanthamoeba keratitis].
authors.forename: Y
authors.initials: Y
authors.lastname: Ishibashi
authors.forename: Y
authors.initials: Y
authors.lastname: Matsumoto
authors.forename: R
authors.initials: R
authors.lastname: Watanabe
authors.forename: S
authors.initials: S
authors.lastname: Hommura
authors.forename: K
authors.initials: K
authors.lastname: Yasuraoka
authors.forename: K
authors.initials: K
authors.lastname: Ishii
authors.forename: T
authors.initials: T
authors.lastname: Koyama
authors.forename: T
authors.initials: T
authors.lastname: Endo
authors.forename: K
authors.initials: K
authors.lastname: Yagita
mesh_terms: D000048:Acanthamoeba; D000328:Adult; D000562:Amebiasis; D000818:Animals; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D017964:Itraconazole; D007634:Keratitis / Q000188:drug therapy / Q000209:etiology*; D007654:Ketoconazole / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D008297:Male; D008825:Miconazole / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D000935:Antifungal Agents; D017964:Itraconazole; D008825:Miconazole; D007654:Ketoconazole